375 related articles for article (PubMed ID: 19903292)
21. Analysis of clinical outcome and survival in pediatric patients undergoing extracorporeal photopheresis for the treatment of steroid-refractory GVHD.
González Vicent M; Ramirez M; Sevilla J; Abad L; Díaz MA
J Pediatr Hematol Oncol; 2010 Nov; 32(8):589-93. PubMed ID: 20962677
[TBL] [Abstract][Full Text] [Related]
22. Extracorporeal photopheresis in children with graft-versus-host disease.
Chan KW
J Clin Apher; 2006 Apr; 21(1):60-4. PubMed ID: 16619229
[TBL] [Abstract][Full Text] [Related]
23. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease.
Rossetti F; Dall'Amico R; Crovetti G; Messina C; Montini G; Dini G; Locatelli F; Argiolu F; Miniero R; Zacchello G
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():175-81. PubMed ID: 8932825
[TBL] [Abstract][Full Text] [Related]
24. Comparison between 8-methoxypsoralen and 5-aminolevulinic acid in killing T cells of photopheresis patients ex vivo.
Holien T; Gederaas OA; Darvekar SR; Christensen E; Peng Q
Lasers Surg Med; 2018 Jul; 50(5):469-475. PubMed ID: 29460964
[TBL] [Abstract][Full Text] [Related]
25. Extracorporeal photophoresis augments function of CD4+CD25+FoxP3+ regulatory T cells by triggering adenosine production.
Schmitt S; Johnson TS; Karakhanova S; Näher H; Mahnke K; Enk AH
Transplantation; 2009 Aug; 88(3):411-6. PubMed ID: 19667946
[TBL] [Abstract][Full Text] [Related]
26. Role for CD4(+)CD25(+) T cells in inhibition of graft rejection by extracorporeal photopheresis.
George JF; Gooden CW; Guo L; Kirklin JK
J Heart Lung Transplant; 2008 Jun; 27(6):616-22. PubMed ID: 18503960
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis induction by extracorporeal photopheresis is enhanced by increasing the 8-methoxypsoralen concentration and by replacing plasma with saline.
Hähnel V; Brosig AM; Ehrenschwender M; Burkhardt R; Offner R; Ahrens N
Transfusion; 2021 Oct; 61(10):2991-2999. PubMed ID: 34427336
[TBL] [Abstract][Full Text] [Related]
28. Successful use of miniphotopheresis for the treatment of graft-versus-host disease.
Hackstein H; Amoros JJ; Bein G; Woessmann W
Transfusion; 2014 Aug; 54(8):2022-7. PubMed ID: 24666366
[TBL] [Abstract][Full Text] [Related]
29. Extracorporeal photopheresis: from solid organs to face transplantation.
Hivelin M; Siemionow M; Grimbert P; Lantieri L
Transpl Immunol; 2009 Jul; 21(3):117-28. PubMed ID: 19409991
[TBL] [Abstract][Full Text] [Related]
30. Extracorporeal photochemotherapy.
Maeda A
J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
[TBL] [Abstract][Full Text] [Related]
31. Plasma and buffy coat concentration of 8-methoxypsoralen in patients treated with extracorporeal photopheresis.
Balogh A; Merkel U; Looks A; Vollandt R; Wollina U
Exp Toxicol Pathol; 1998 Sep; 50(4-6):397-401. PubMed ID: 9784014
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of lymphocytes inactivation by extracorporeal photopheresis using tetrazolium salt based-assay.
Chieregato K; Alghisi A; Borghero C; Elice F; Raimondi R; Zanetti E; Rodeghiero F; Astori G
Transfus Apher Sci; 2015 Oct; 53(2):242-5. PubMed ID: 26051797
[TBL] [Abstract][Full Text] [Related]
33. Extracorporeal photophoresis increases sensitivity of monocytes from patients with graft-versus-host disease to HLA-DR-mediated cell death.
Setterblad N; Garban F; Weigl R; Assier E; Drillat P; Charron D; Dickinson A; Greinix H; Mooney N
Transfusion; 2008 Jan; 48(1):169-77. PubMed ID: 17900279
[TBL] [Abstract][Full Text] [Related]
34. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease.
Bladon J; Taylor P
Ther Apher Dial; 2008 Aug; 12(4):311-8. PubMed ID: 18789119
[TBL] [Abstract][Full Text] [Related]
35. Update on extracorporeal photochemotherapy for graft-versus-host disease treatment.
Kanold J; Messina C; Halle P; Locatelli F; Lanino E; Cesaro S; Deméocq F;
Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S69-71. PubMed ID: 15812535
[TBL] [Abstract][Full Text] [Related]
36. Update on the mechanism of action and on clinical efficacy of extracorporeal photopheresis in the treatment of acute and chronic graft versus host disease in children.
Goussetis E; Varela I; Tsirigotis P
Transfus Apher Sci; 2012 Apr; 46(2):203-9. PubMed ID: 22079263
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of action of extracorporeal photochemotherapy.
Heshmati F
Transfus Apher Sci; 2003 Aug; 29(1):61-70. PubMed ID: 12877896
[TBL] [Abstract][Full Text] [Related]
38. Extracorporeal photopheresis: a review.
Oliven A; Shechter Y
Blood Rev; 2001 Jun; 15(2):103-8. PubMed ID: 11409910
[TBL] [Abstract][Full Text] [Related]
39. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.
Perfetti P; Carlier P; Strada P; Gualandi F; Occhini D; Van Lint MT; Ibatici A; Lamparelli T; Bruno B; Raiola AM; Dominietto A; Di Grazia C; Bregante S; Zia S; Ferrari GM; Stura P; Pogliani E; Bacigalupo A
Bone Marrow Transplant; 2008 Nov; 42(9):609-17. PubMed ID: 18660840
[TBL] [Abstract][Full Text] [Related]
40. Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients.
Bladon J; Taylor PC
Br J Haematol; 1999 Dec; 107(4):707-11. PubMed ID: 10606873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]